162 related articles for article (PubMed ID: 34026068)
1. lncRNA MAGI2-AS3 overexpression had antitumor effect on Hepatic cancer via miRNA-23a-3p/PTEN axis.
Liu F; Deng W; Wan Z; Xu D; Chen J; Yang X; Xu J
Food Sci Nutr; 2021 May; 9(5):2517-2530. PubMed ID: 34026068
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis.
Hao XZ; Yang K
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127
[TBL] [Abstract][Full Text] [Related]
3. lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis.
Wei H; Tang Q; Wang A; Zhang Y; Qin Z; Li W; Xu Z; Wang J; Pu J
J Oncol; 2021; 2021():5547345. PubMed ID: 34484334
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MAGI2-AS3 Affects Cell Invasion and Migration of Cervical Squamous Cell Carcinoma (CSCC) via Sponging miRNA-233/EPB41L3 Axis.
Hou A; Zhang Y; Fan Y; Zheng Y; Zhou X; Liu H
Cancer Manag Res; 2020; 12():4209-4216. PubMed ID: 32581592
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MAGI2-AS3 promotes fracture healing through downregulation of miR-223-3p.
Dong Z; Hu B; Wang S; Wang M; Sun S; Liu X; Li D; Wu D
J Orthop Surg Res; 2024 Jun; 19(1):370. PubMed ID: 38907263
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MAGI2-AS3 is downregulated in the distant recurrence of hepatocellular carcinoma after surgical resection and affects migration and invasion via ROCK2.
Fang G; Wang J; Sun X; Xu R; Zhao X; Shao L; Sun C; Wang Y
Ann Hepatol; 2020; 19(5):535-540. PubMed ID: 32546442
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MAGI2-AS3 inhibites tumor progression by up-regulating STAM via interacting with miR-142-3p in clear cell renal cell carcinoma.
Yang R; Chen Z; Ao S; Liang L; Chen Z; Duan X; Zeng G; Deng T
Cell Signal; 2024 Jan; 113():110954. PubMed ID: 38084836
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MAGI2-AS3 Inhibits Prostate Cancer Progression by Targeting the miR-142-3p.
Hu R; Wu P; Liu J
Horm Metab Res; 2022 Nov; 54(11):754-759. PubMed ID: 35944561
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MAGI2-As3 Suppresses the Proliferation and Invasion of Cervical Cancer by Sponging MiR-15b.
Chai Y; Wang L; Qu Y; Hu Z
J Healthc Eng; 2022; 2022():9707206. PubMed ID: 35126958
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MAGI2-AS3 acts as a tumor suppressor that attenuates non-small cell lung cancer progression by targeting the miR-629-5p/TXNIP axis.
Gong J; Ma L; Peng C; Liu J
Ann Transl Med; 2021 Dec; 9(24):1793. PubMed ID: 35071487
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA MAGI2-AS3 inhibits bladder cancer progression through MAGI2/PTEN/epithelial-mesenchymal transition (EMT) axis.
Shen D; Xu J; Cao X; Cao X; Tan H; Deng H
Cancer Biomark; 2021; 30(2):155-165. PubMed ID: 33104021
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA MAGI2-AS3 inhibits breast cancer cell migration and invasion via sponging microRNA-374a.
Du S; Hu W; Zhao Y; Zhou H; Wen W; Xu M; Zhao P; Liu K
Cancer Biomark; 2019; 24(3):269-277. PubMed ID: 30883342
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a.
Li D; Wang J; Zhang M; Hu X; She J; Qiu X; Zhang X; Xu L; Liu Y; Qin S
Mol Ther Nucleic Acids; 2020 Mar; 19():109-123. PubMed ID: 31837602
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MAGI2-AS3 inhibits tumor progression and angiogenesis by regulating ACY1 via interacting with transcription factor HEY1 in clear cell renal cell carcinoma.
Wang G; Li H; Hou Y
Cancer Gene Ther; 2022 May; 29(5):585-596. PubMed ID: 34002044
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding MAGI2-AS3 Suppresses Several Cellular Processes of Lung Squamous Cell Carcinoma Cells by Regulating miR-374a/b-5p/CADM2 Axis.
He J; Zhou X; Li L; Han Z
Cancer Manag Res; 2020; 12():289-302. PubMed ID: 32021443
[TBL] [Abstract][Full Text] [Related]
16. CircFBXW7 alleviates glioma progression through regulating miR-23a-3p/PTEN axis.
Gao ZG; Yang P; Huang J; Ding YQ
Anat Rec (Hoboken); 2021 Feb; 304(2):279-290. PubMed ID: 32365279
[TBL] [Abstract][Full Text] [Related]
17. MAGI2-AS3 and miR-374b-5p as Putative Regulators of Multiple Sclerosis via Modulating the PTEN/AKT/IRF-3/IFN-β Axis: New Clinical Insights.
Kortam MA; Elfar N; Shaker OG; El-Boghdady NA; Abd-Elmawla MA
ACS Chem Neurosci; 2023 Mar; 14(6):1107-1118. PubMed ID: 36878000
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p/SMG1 signaling pathway.
Yin Z; Ma T; Yan J; Shi N; Zhang C; Lu X; Hou B; Jian Z
J Cell Physiol; 2019 Aug; 234(10):18825-18836. PubMed ID: 30924168
[TBL] [Abstract][Full Text] [Related]
19. Role of lncRNA MAGI2-AS3 in lipopolysaccharide-induced nucleus pulposus cells injury by regulating miR-374b-5p/interleukin-10 axis.
Yu J; Li C
Immun Inflamm Dis; 2023 Apr; 11(4):e772. PubMed ID: 37102649
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding MAGI2-AS3 promotes colorectal cancer progression through regulating miR-3163/TMEM106B axis.
Ren H; Li Z; Tang Z; Li J; Lang X
J Cell Physiol; 2020 May; 235(5):4824-4833. PubMed ID: 31709544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
